GeneDx Holdings Corp (WGS)
20.47
-0.13
(-0.63%)
USD |
NASDAQ |
May 28, 10:49
GeneDx Holdings Enterprise Value: 478.09M for May 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 24, 2024 | 478.09M |
May 23, 2024 | 455.08M |
May 22, 2024 | 462.14M |
May 21, 2024 | 482.01M |
May 20, 2024 | 508.42M |
May 17, 2024 | 524.90M |
May 16, 2024 | 567.53M |
May 15, 2024 | 492.73M |
May 14, 2024 | 497.70M |
May 13, 2024 | 550.79M |
May 10, 2024 | 482.01M |
May 09, 2024 | 470.77M |
May 08, 2024 | 443.31M |
May 07, 2024 | 443.83M |
May 06, 2024 | 449.85M |
May 03, 2024 | 453.51M |
May 02, 2024 | 449.32M |
May 01, 2024 | 486.46M |
April 30, 2024 | 385.78M |
April 29, 2024 | 227.04M |
April 26, 2024 | 229.13M |
April 25, 2024 | 231.49M |
April 24, 2024 | 248.48M |
April 23, 2024 | 253.08M |
April 22, 2024 | 210.99M |
Date | Value |
---|---|
April 19, 2024 | 191.39M |
April 18, 2024 | 189.56M |
April 17, 2024 | 179.88M |
April 16, 2024 | 190.60M |
April 15, 2024 | 197.66M |
April 12, 2024 | 190.68M |
April 11, 2024 | 231.69M |
April 10, 2024 | 241.35M |
April 09, 2024 | 222.55M |
April 08, 2024 | 212.10M |
April 05, 2024 | 200.34M |
April 04, 2024 | 175.79M |
April 03, 2024 | 186.24M |
April 02, 2024 | 183.10M |
April 01, 2024 | 175.27M |
March 31, 2024 | 177.88M |
March 28, 2024 | 160.91M |
March 27, 2024 | 169.50M |
March 26, 2024 | 150.75M |
March 25, 2024 | 143.97M |
March 22, 2024 | 147.36M |
March 21, 2024 | 162.21M |
March 20, 2024 | 144.75M |
March 19, 2024 | 142.41M |
March 18, 2024 | 174.71M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-93.99M
Minimum
Dec 28 2022
2.855B
Maximum
Aug 11 2021
392.09M
Average
181.10M
Median
Nov 10 2022
Enterprise Value Benchmarks
GE HealthCare Technologies Inc | 43.34B |
Spok Holdings Inc | 284.39M |
Ontrak Inc | 8.183M |
DarioHealth Corp | 46.76M |
FOXO Technologies Inc | 7.113M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -20.24M |
Revenue (Quarterly) | 62.42M |
Total Expenses (Quarterly) | 76.08M |
EPS Diluted (Quarterly) | -0.78 |
Gross Profit Margin (Quarterly) | 59.93% |
Profit Margin (Quarterly) | -32.42% |
Earnings Yield | -25.31% |
Normalized Earnings Yield | -23.48 |